statin treatment rescues fgfr3 skeletal dysplasia phenotypes 
gain-of-function mutations fibroblast growth factor receptor gene fgfr3 result skeletal dysplasias thanatophoric dysplasia achondroplasia ach lack disease models using human cells hampered identification clinically effective treatment diseases show statin treatment can rescue patient-specific induced pluripotent stem cell ipsc models mouse model fgfr3 skeletal dysplasia converted fibroblasts thanatophoric dysplasia type td1 ach patients ipscs chondrogenic differentiation td1 ipscs ach ipscs resulted formation degraded cartilage found statins correct degraded cartilage chondrogenically differentiated td1 ach ipscs treatment ach model mice statin led significant recovery bone growth results suggest statins represent medical treatment infants children td1 ach 
